Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Payables (2020 - 2025)

Journey Medical's Payables history spans 6 years, with the latest figure at $8.9 million for Q4 2025.

  • For the quarter ending Q4 2025, Payables fell 44.85% year-over-year to $8.9 million, compared with a TTM value of $8.9 million through Dec 2025, down 44.85%, and an annual FY2025 reading of $8.9 million, down 44.85% over the prior year.
  • Payables for Q4 2025 was $8.9 million at Journey Medical, down from $11.6 million in the prior quarter.
  • The five-year high for Payables was $36.6 million in Q4 2022, with the low at $74000.0 in Q3 2022.
  • Average Payables over 5 years is $15.6 million, with a median of $15.0 million recorded in 2024.
  • Year-over-year, Payables plummeted 87.67% in 2022 and then skyrocketed 37959.46% in 2023.
  • Tracing DERM's Payables over 5 years: stood at $22.8 million in 2021, then soared by 60.31% to $36.6 million in 2022, then tumbled by 50.37% to $18.1 million in 2023, then dropped by 11.57% to $16.0 million in 2024, then crashed by 44.85% to $8.9 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Payables are $8.9 million (Q4 2025), $11.6 million (Q3 2025), and $12.8 million (Q2 2025).